このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
COMPASS Pathways マネジメント
マネジメント 基準チェック /44
COMPASS Pathways'の CEO はKabir Nathで、 Aug2022年に任命され、 の在任期間は 1.83年です。 の年間総報酬は$ 2.82Mで、 21%給与と79%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.038%を直接所有しており、その価値は$ 166.82K 。経営陣と取締役会の平均在任期間はそれぞれ2.4年と4年です。
主要情報
Kabir Nath
最高経営責任者
US$2.8m
報酬総額
| CEO給与比率 | 21.0% |
| CEO在任期間 | 1.9yrs |
| CEOの所有権 | 0.04% |
| 経営陣の平均在職期間 | 2.4yrs |
| 取締役会の平均在任期間 | 4yrs |
経営陣の近況
Recent updates
Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies
Jul 08Psychedelics Closer To Commercialization; Compass Far And Away The Leader
May 23COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?
Apr 25Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play
Feb 08Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth
Dec 06
Booker again pushes for easier access to psychedelics for terminally ill patients
Oct 19Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation
Aug 13COMPASS Pathways And The Trillion Dollar Opportunity
Aug 11COMPASS Pathways ADS Q2 2022 Earnings Preview
Aug 03COMPASS Pathways names new CEO
Jul 19Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy
Jun 30We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely
Apr 28Checking In On Compass Pathways
Mar 02We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth
Dec 29Compass Pathways: Psychedelics For Mental Health
Nov 23Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy
Sep 17COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
Sep 15Compass Pathways: Huge Growth Potential, But I'm Cautious
Jun 04COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
May 25COMPASS Pathways raises $144M capital via equity offering
Apr 30COMPASS Pathways launches public offering
Apr 27We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate
Feb 08Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront
Jan 01Compass Pathways: Risky And Overvalued
Dec 18What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?
Dec 18COMPASS Pathways: Risky But Can Pay Back Generously
Dec 14Compass Pathways: An Overvalued Psychedelic Company With A Single Mediocre Drug
Nov 23COMPASS Pathways ADS reports Q3 results
Nov 12CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$129m |
| Dec 31 2023 | US$3m | US$595k | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$117m |
| Jun 30 2023 | n/a | n/a | -US$102m |
| Mar 31 2023 | n/a | n/a | -US$95m |
| Dec 31 2022 | US$8m | US$243k | -US$92m |
報酬と市場: Kabirの 総報酬 ($USD 2.82M ) は、 US市場 ($USD 2.44M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Kabirの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Kabir Nath (60 yo)
1.9yrs
在職期間
US$2,824,758
報酬
Mr. Kabir Kumar Nath M. A., M. B.A., is Chief Executive Officer and Director of COMPASS Pathways plc from August 1, 2022. He serves as President & CEO at Otsuka America Pharmaceutical, Inc. He served as Pr...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 1.9yrs | US$2.82m | 0.038% $ 187.3k | |
| General Counsel & Chief Legal Officer | 2.4yrs | US$1.32m | 0.0059% $ 29.2k | |
| Chief Medical Officer | 3yrs | US$1.20m | 0.0029% $ 14.4k | |
| CFO, Principal Financial Officer & Principal Accounting Officer | less than a year | データなし | データなし | |
| Chief Technology Officer | 2.5yrs | データなし | データなし | |
| Senior Vice President of Investor Relations | no data | データなし | データなし | |
| Chief Communications Officer | 1.8yrs | データなし | データなし | |
| Chief People Officer | no data | データなし | データなし | |
| Senior Advisor | 2.5yrs | データなし | データなし | |
| Chief Development Officer | 4.1yrs | データなし | データなし | |
| Advisor | no data | データなし | データなし | |
| Chief Research & Development Officer | less than a year | データなし | データなし |
2.4yrs
平均在職期間
55.5yo
平均年齢
経験豊富な経営陣: CMPSの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 1.9yrs | US$2.82m | 0.038% $ 187.3k | |
| Member of Scientific Advisory Network | no data | データなし | データなし | |
| Independent Non Executive Director | 3.8yrs | US$209.48k | 0% $ 0 | |
| Independent Chairman & Lead Independent Director | 6.2yrs | US$215.57k | 0.025% $ 125.6k | |
| Independent Director | less than a year | US$363.71k | 0% $ 0 | |
| Independent Non Executive Director | 4.3yrs | US$210.84k | 0% $ 0 | |
| Independent Non-Executive Director | 3.3yrs | US$200.86k | 0% $ 0 | |
| Independent Non-Executive Director | 6.2yrs | US$199.82k | 0.13% $ 643.0k | |
| Independent Non-Executive Director | 6.2yrs | US$214.78k | 0.049% $ 242.3k | |
| Member of Scientific Advisory Network | no data | データなし | データなし | |
| Member of Scientific Advisory Network | no data | データなし | データなし | |
| Special Advisor of Patient Experience | no data | データなし | データなし |
4.0yrs
平均在職期間
67yo
平均年齢
経験豊富なボード: CMPSの 取締役会 は 経験豊富 であると考えられます ( 4年の平均在任期間)。